Indication

Migraine Prophylaxis

1 clinical trial

1 product

Clinical trial

Effect of Nicotinic Acid as add-on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial

Status: Recruiting, Estimated PCD: 2024-01-10

Product